Milan, June 3rd, 2008 – Indena, the world’s leading company dedicated to the identification, development and production of active principles derived from plants, today announced that it has been chosen by Frost & Sullivan as the winner of the 2008 European Green Tea Extracts Excellence in Research Award. Indena is honored to receive this award as support of its work in providing effective extracts for its customers.
Each year, the Frost & Sullivan Excellence in Research Award is given to the company that has carried out new disruptive research and has, in general, a strong commitment to research and development. The Award recognizes a research and development program that has or is expected to bring significant contributions to the industry in terms of adoption, change and competitive posture. The Award also recognizes the overall research excellence of a company as well as its commitment toward differentiating itself based on science-backed services or solutions.
According to Frost & Sullivan, the 2008 European Green Tea Extracts Excellence in Research Award is presented to Indena “having established itself as a key player in the natural extracts sector for over 80 years. Indena entered the green tea extracts market in the late 1980’s and since then has gone from strength to strength by focussing on intensive research into these extracts. Indena has effectively sustained its market reputation as an organisation dedicated to research. The company has chosen to rest it claim on the green tea market by developing superior research capabilities. Moreover its impressive tie-ups with academia, scientific journals and public image have greatly contributed to its market credibility. In addition, its innovative and market responsive product solutions have also helped ensure Indena’s leading presence in the green tea extract market. The company is recognised for its perceptive innovations that best fit the industry and consumer trends. It has a fine culture of encouraging inspiring dialogues between the internal research and development experts and customers. Today Indena is the leader in terms of safety, efficacy, innovation and its standardized extracts are the point of reference for the market. Such comprehensive and outstanding position in research endorses Indena as the worthy recipient of the 2008 European Green Tea Extracts Excellence in Research Award”.
As the green tea market has seen rapid growth and become highly competitive in recent years, many new companies have offered green tea extracts varying considerably in quality. With its 20 years of green tea market commitment, Indena has concentrated on the research both to validate the efficacy of their products and to support new market applications helping grow the green tea market. Customers utilizing Indena green tea extracts have benefited from this investment and are assured product safety and effectiveness.
Indena offers Greenselect® green tea extract that consists of a totally standardized polyphenolic fraction obtained from green tea leaves. Indena introduced its caffeine-free extract from green tea leaves, characterized by a high content (not less than 66.5%) of polyphenols, with the main constituent epigallocatechin 3-O-gallate accounting for not less than 50% of the extract. Greenselect® is thus aimed at the health food and cosmetics markets as its antioxidant effect is a major tool in averting against free radical-induced tissue damage.
The Award will be presented on November 11th at the Frost & Sullivan Banquet in London.
Indena is the world's leading company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health food and cosmetics industries. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits, the identification of new active principles and the development of extraction and purification systems at the cutting-edge of industrial application. Backed up by over 80 years of botanical experience, the phyto-chemical research is carried out in Indena's own Settala Research Center, near Milan. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. The company has more than 150 primary patents and has published around 700 scientific studies. Indena, with more than 700 employees, including 10% dedicated to full-time research, manages cultivation, manufacturing, and distribution operations in more than 40 countries. Headquartered in Milan, Indena has 5 production sites and 5 international branches throughout the world. The Company's experts communicate and interact constantly with the major international regulatory authorities such as WHO, EMEA, and ESCOP, and work with all the main pharmacopoeias.
Further Information on Indena: